F. Villinger et al., Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules, IMMUNOGENET, 53(4), 2001, pp. 315-328
The finding that a single administration of select recombinant human cytoki
nes to nonhuman primates leads to potent cytokine -neutralizing antibody re
sponses in the heterologous host despite > 95% homology at the nucleotide a
nd protein level prompted our laboratory to clone, sequence, and prepare re
combinant nonhuman primate cytokines, chemokines, growth factors, and other
immunoregulatory molecules. In the present report, we present findings on
the gene sequences encoding the nonhuman primate homologues of human CD80,
CD86, their ligands CD28 and CD152, CD154, CD95, and CD95-L from rhesus mac
aques and for phylogenetic analysis from pig-tailed macaques, African sooty
mangabey monkeys, baboons, and vervets as well as select molecules from th
e New World aotus and marmoset monkeys. With the exception of CD95, the hom
ology between nonhuman primate and human co-stimulatory molecules was above
95%. In contrast, CD95 was only 89.2% homologous to human CD95, but the di
fferences were essentially found in the transmembrane and intracellular (de
ath) domains. The extracellular portion of CD95 was more homologous which w
as in accordance with approximately 98% homology between Old World monkey a
nd human CD95-L. In general, sequences from the New World monkey species ap
peared equidistant to sequences from Old World species and humans in terms
of homology suggesting distinct evolutionary patterns. Of interest was the
isolation of various splice variants of monkey CD86, CD152 (CTLA-4), CD154,
and CD95 transcripts. This is also the first report documenting the occurr
ence of natural CD86 variants with deleted transmembrane domains, found bot
h in sooty mangabeys and baboon RNA samples. Monkey CD95 showed various del
etions and addition of residues in the transmembrane and intracytoplasmic d
omains compared with human CD95 and between Old and New World species. Subc
loning of rhesus CD154 into an expression vector demonstrated expression of
a functional protein in cell culture. The other genes are being cloned int
o expression vectors for the preparation and biological characterization of
the nonhuman primate molecules. These investigations will provide novel re
agents for in vivo use as immunomodulatory reagents in nonhuman primates in
studies which may provide a rationale for their use in humans.